S2: Episode 1. Making a Choice Leading the Charge
-
- Science
As S-ICD technology continues to establish itself as a preferred alternative to transvenous cardiac defibrillators, the pre-implant conversation with ICD patients has quickly evolved. Join host Wyatt Stahl and special guest Dr. Martin C. Burke as they trace S-ICD’s historic journey in defibrillation therapy from niche to norm—and what it means for patient selection.
“I really think that the S-ICD, as a platform, is your go-to platform right off the bat.”
Martin C. Burke, electrophysiologist
Disclosure: Dr. Burke is a consultant with Boston Scientific.
For more information regarding S-ICD and its indications for use, visit bostonscientific.com/sicd.
For more information regarding S-ICD usage within the EU, visit bostonscientific.eu/s-icd.
For more S-ICD implantation resources and best practices, visit sicdtraining.com.
As S-ICD technology continues to establish itself as a preferred alternative to transvenous cardiac defibrillators, the pre-implant conversation with ICD patients has quickly evolved. Join host Wyatt Stahl and special guest Dr. Martin C. Burke as they trace S-ICD’s historic journey in defibrillation therapy from niche to norm—and what it means for patient selection.
“I really think that the S-ICD, as a platform, is your go-to platform right off the bat.”
Martin C. Burke, electrophysiologist
Disclosure: Dr. Burke is a consultant with Boston Scientific.
For more information regarding S-ICD and its indications for use, visit bostonscientific.com/sicd.
For more information regarding S-ICD usage within the EU, visit bostonscientific.eu/s-icd.
For more S-ICD implantation resources and best practices, visit sicdtraining.com.
11 min